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SUMMARY
Purpose: A diagnostic feature of focal cortical dysplasia
(FCD) type II on magnetic resonance imaging (MRI) is
increased subcortical white matter (WM) signal on T2
sequences corresponding to hypomyelination, the cause
of which is unknown. We aimed to quantify WM pathol-
ogy in FCD type II and any deficiency in the numbers and
differentiation of oligodendroglial (OL) cell types within
the dysplasia.
Methods: In 19 cases we defined four regions of interests
(ROIs): ROI1 = abnormal WM beneath dysplasia, ROI2 =
dysplastic cortex, ROI3 = normalWM, andROI4 = normal
cortex. We quantified axonal and myelin density using
immunohistochemistry for neurofilament, myelin basic
protein and quantified mature OL with NogoA, cyclic
nucleotide 3-phosphodiesterase (CNPase) and OL precur-
sor cell (OPC) densities with platelet derived growth factor
receptor (PDGFR)a, b andNG-2 in each region.
Key Findings: We observed a significant reduction inmye-
lin and axons in the WM beneath dysplasia relative to
normalWM and there was a correlation between relative
reduction of myelin and neurofilament in each case. OL
and OPC were present in the WM beneath dysplasia and
although present in lower numbers with most markers,
were not significantly different from normal WM. Neuro-
filament and myelin labeling highlighted disorganized ori-
entation of fibers in dysplastic cortex but there were no
significant quantitative differences compared to normal
cortex. Clinical correlations showed an association
between the severity of reduction of myelin and axons in
theWMof FCD and duration of epilepsy.
Significance: These findings indicate a reduction of mye-
linated axons in the WM of FCD type II rather than
dysmyelination as the primary pathologic process under-
lying WM abnormalities, possibly influenced by duration
of seizures. The range of OPC to OL present in FCD type
II does not implicate a primary failure of cell recruitment
and differentiation of these cell types in this pathology.
KEY WORDS: Focal cortical dysplasia type II, White
matter, Myelination, Oligodendroglia.
In the first descriptions of the neuropathology now known
as focal cortical dysplasia type II (FCD II), Corsellis and
Bruton noted that the adjacent white matter (WM) was
poorly myelinated (Taylor et al., 1971). Despite numerous
subsequent histopathologic studies based on epilepsy surgi-
cal series, this component of the pathology, in particular
with regard to the origin of the reduced myelin, has
remained relatively unexplored. (Blumcke et al., 2011).
Diagnostic magnetic resonance imaging (MRI) features
of FCD II take into account WM abnormalities, visualized
as blurring of the gray-white interface or increased subcorti-
cal signal on T2 and fluid-attenuated inversion recovery
(FLAIR) images (Urbach et al., 2002; Blumcke et al.,
2011). FCD II on MRI can be limited to the bottom of a
sulcus (Barkovich et al., 1997), with local increased WM
signal intensity (Hofman et al., 2011), or form an extensive
“transmantle dysplasia” where abnormal signal extends to
the margin of the ventricle (Barkovich et al., 1997).
Furthermore, in some pathology-proven cases of FCD II,
MRI changes are subtle or overlooked (Oster et al., 2012;
Regis et al., 2011). These observations suggest that the
extent of WM pathology within the spectrum of FCD II
lesions is highly variable. Diffusion tensor imaging (DTI)
studies in FCD have aimed to specifically address the extent
of WM pathology (Eriksson et al., 2001; Widjaja et al.,
2007; Diehl et al., 2010), which in addition to diagnostic
value may be of functional relevance to the exploration of
abnormal cortical connections (Riley et al., 2010).
FCD II is widely regarded as a developmental abnormal-
ity with several lines of evidence pointing to a disturbance
in the migration and differentiation of radial glial stems
cells and their progeny to the cortical plate (Andres et al.,
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2005; Cepeda et al., 2006; Lamparello et al., 2007;
Sisodiya et al., 2009; Hadjivassiliou et al., 2010). The
contribution of myelinating oligodendroglia (OL), and their
progenitor and precursor cell populations oligodendroglial
progenitor cells (OPCs), has not been specifically investi-
gated in FCD II lesions and, in particular, if aberrant matu-
ration could be implicated in the pathoetiology of abnormal
myelination.
Our aim was to examine the patterns of myelination in a
series of FCD II lesions operated on in childhood and adult-
hood for the treatment of drug-resistant epilepsy as well as
cases confirmed at postmortem. We aimed to quantify the
extent of the WM abnormalities and the composition of OL
and OPC populations in these regions.
Methods
Case selection
Seventeen cases with a neuropathologic diagnosis of
FCD II (Blumcke et al., 2011) were selected from the epi-
lepsy surgical databases in the departments of neuropathol-
ogy, Institutes of Neurology and Child Heath, operated
over a period from 1996 to 2009 in addition to two cases
diagnosed at postmortem examination. The study has been
approved by the Joint Research Ethics Committee of the
National Hospital for Neurology and Neurosurgery and the
Institute of Neurology. Thirteen cases were operated in
adulthood and four in childhood. In one of the cases the
histologic diagnosis was FCD type IIA and in the remain-
ing 18 cases, type IIB with balloon cells (Blumcke et al.,
2011). We included the one type IIA case because although
no balloon cells were identified on serial sections, white
matter abnormalities were present similar to typical type
IIB cases. Cases were selected that had undergone more
extensive resections, where in addition to the region of
dysplasia, more normally laminated cortex was available in
the same specimen for comparison. All patients had histo-
ries of drug-resistant epilepsy, and standard presurgical
investigations were carried out, including MRI, prior to
surgical resection. The preoperative diagnosis on MRI in
the adult surgical cases had been FCD, although an uncer-
tain diagnosis or possible dysembryoplastic neuroepithelial
tumor was proposed in three cases. However, in adult
surgical cases, a retrospective review of preoperative MRI
confirmed WM signal abnormalities on T2-weighted and
fluid-attenuated inversion recovery (FLAIR) sequences in
the region of the dysplasia, typical of FCD II in all but one
patient. Clinical details of all 19 cases, including seizure
history and outcome data following resection, are presented
in Table 1.
Immunohistochemistry
Sections were cut at a thickness of 7 lm from one repre-
sentative block; in two cases, two blocks were selected that
contained the region of dysplasia in one and more normal
cortex in another. Immunohistochemistry was carried out
Table 1. Clinical data of the 19 cases of FCD type II
Case FCD type
Age at seizure
onset (years) Seizure type Localization
Age at Surgery
or at deatha (years)
Outcome at
follow-up at 2 years
1 FCD IIB 0.9 SPS, CPS Left frontal 24 1a
2 FCD IIB 1.4 CPS; SGS Left frontal 52 1
3 FCD IIB 1 SPS; CPS; SGS (rare) Right frontal 22 1
4 FCD IIB 4 SPS; CPS; SGS Right frontal 46 1
5 FCD IIB 5 SPS; CPS; SGS Left frontal 26 5
6 FCD IIA 7 SPS; CPS; SGS Right parietal 18 4
7 FCD IIB 7 CPS; SGS (in past) Temporal 30 4
8 FCD IIB 3 SPS; CPS; SGS Right temporal 52 4
9 FCD IIB 12 CPS; SGS Right temporal 26 2
10 FCD IIB 11 CPS, SGS Left parietal 25 3a
11 FCD IIB 12 SGS, right head versive seizures,
left leg tonic seizures,
Left frontal 29 Unknown
12 FCD IIB 12 SGS, atonic seizures Parietal 32 2
13 FCD IIB 7 SGS, CPS Frontal 34 1
14 FCD IIB 5 SGS Frontal 81a Not applicable
15 FCD IIB 3 CPS, SGS, SPS Right frontal 59a Not applicable
16 FCD IIB 4 FS, SGS Right parietal 13 1 Not seizure-free (11 years)
17 FCD IIB 0.5 CPS, SE Right frontal 6 Not seizure-free (10 years)
18 FCD IIB 0.08 Clonic jerks Left frontal 3 1
19 FCD IIB 0 SGS, drop attacks, atonic seizures. Left frontal 18 Unknown
SPS, simple partial seizure; SGS, secondary generalized seizures; CPS, complex partial seizures; FS, febrile seizures.
The postoperative outcome is classified according to International League Against Epilepsy (ILEA) 2001 outcome criteria for adult surgical cases; class 1 being
seizure-free to class 5 having 50% reduction in seizures. The data are recorded at 2 years follow-up. For two cases a data were available for only 1 year follow-up,
and in seven patients longer follow-ups of up of 14 years (where there was a change in ILAE outcome this is noted in the table). In two patients there was no post-
operative clinical follow-up and on the two postmortem patients (cases 14 and 15) this was not applicable as they had not had surgery.
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using standard methods with a panel of primary antibodies
(Table 2), visualized with diaminobenzidine chromagen
(Dako Envision Dako, Cambridge, United Kingdom).
In addition, double-labeling immunofluorescence was
carried out on selected cases for combinations of: platelet
derived growth factor receptor (PDGFR)a/b, PDGFRa/glial
fibrillary acidic protein (GFAP), PDGFRa/CD45, and
PDGFRa/HLADR. In brief, sections were incubated over-
night with primary antibody. Dako Envision horseradish
peroxide solution was applied for 30 min before fluores-
cein-labeled antibody. Sections were thoroughly washed
before second antibody applied. Alexa Fluor 564 conju-
gated anti-rabbit (1:100; Molecular Probes, Invitrogen,
Carlsbad, CA, U.S.A.) and/or Alexa Fluor 633 conjugated
antimouse secondary antibodies (1:50; Molecular Probes,
Invitrogen) in Dako diluent were incubated on sections for
3 h at room temperature. Sections were coverslipped in
DAPI-mounting media (Vector Laboratories, Burlingame,
CA, U.S.A.). Immunofluorescent-labeled sections were
viewed under a confocal laser scanning microscope (Zeiss
LSM610 Meta, Cambridge, United Kingdom) equipped
with blue diode (405 nm), argon (458, 477, 488, and
514 nm), and helium/neon (546 and 633 nm) lasers.
Qualitative analysis
Qualitative analysis of myeloarchitecture was undertaken
on Luxol Fast Blue (LFB) myelin-stained sections in
addition to the immunohistochemistry stains. The region of
dysplasia and underlying WM were compared to the more
normal adjacent cortex.
Quantitative analysis
Four regions of interest (ROIs) were defined in each
case as follows: ROI1, subcortical WM in region of dyspla-
sia; ROI2, dysplastic cortex (full thickness) overlying
ROI1; ROI3, normal WM in adjacent cortex; ROI4, normal
cortex (full thickness) overlying ROI3 (Fig. 1).The ROIs
were defined on LFB-stained sections in each case and cor-
responding regions outlined on immunostained sections.
For image acquisition, each section was viewed under a
Zeiss microscope (Carl Zeiss, Axioscope). Each of the four
ROIs were outlined by a freehand-drawn shape using an
image analysis system (Image Pro Plus, Media Cybernetics,
Marlow, United Kingdom and Histometrix, Kinetic Ima-
ging, Liverpool, United Kingdom) at objective92.5 magni-
fication. Images were systematically acquired from each
drawn ROI at high magnification (920 or 940 objective)
using 100% field sampling. The areas of the ROI1–4 varied
between and within cases from 4.4 to 9.5 mm2.
We used threshold-based analysis to quantify the density
of immunostaining for myelin (myelin basic protein/SMI94
and cyclic nucleotide 3-phosphodiesterase [CNPase]),
axons (phosphorylated neurofilament/SMI31), and den-
drites (microtubule associated protein MAP2) for each ROI
(using Image Pro Plus). A threshold mask was set with red,
green, blue (RGB) parameters to maximize recognition of
fiber staining but elimination of nonaxonal structures. In
particular, staining of neuronal cell bodies with SMI31 was
excluded from the analysis. The same threshold mask was
applied to all images of each ROI of the same immuno-
stained section of each case. The data from each ROI was
Table 2. Details of immunohistochemistry panel and protocols
Antibody: Target cell/structure Antibody clone Source Dilution Pretreatments
Phosphorylated neurofilaments: Axons SMI31 Sternberger Monoclonals,
Baltimore, MD, U.S.A.
1:5,000 None
Nonphosphorylated neurofilaments:
Axons and neurons
SMI32 Sternberger Monoclonals 1:500 EDTA heat-mediated epitope
retrieval, 100°C for 20 min
Myelin basic protein: Mature myelinated axons SMI94 Sternberger Monoclonals 1:2,000 Enzyme pretreatment at
room temperature for 10 min
MAP2, microtubule associated protein:
Dendritic labeling
Map2 Sigma-Aldrich, Dorset,
United Kingdom
1:1,000 Citrate heat-mediated
epitope retrieval,
100°C for 30 min
Reticulon family protein:
Mature oligodendroglia
NogoA Chemicon, Temecula, CA, U.S.A. 1:500 Citrate Heat-mediated
epitope retrieval,
100°C for 20 min
Cyclic nucleotide 3-phosphodiesterase:
Mature oligodendroglia, myelin, and
oligodendroglial precursor cells
CNPase Chemicon 1:400 Vector citrate-based antigen
retrieval buffer, microwave
for 15 min
Chondroitin sulphate proteoglycan:
oligodendroglial precursor cells
NG2 anti-rabbit
polyclonal
Chemicon 1: 100 Vector citrate-based antigen
retrieval buffer, microwave
for 18 min
Platelet derived growth factor receptor alpha:
oligodendroglial precursor cells
PDGF R a anti-rabbit
polyclonal
Gift, B Stallcup 1:600 Vector citrate-based antigen
retrieval buffer, microwave
for 18 min
Platelet derived growth factor receptor beta:
oligodendroglial precursor cells
PDGF R b Abcam plc, Cambridge,
United Kingdom
1:800 Vector citrate-based antigen
retrieval buffer, microwave
for 12 min
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summarized as a percentage of overall staining (labeling
index).
Systematic cell counting was carried out in immuno-
stained sections for OL (NogoA and CNPase) and OPC
(NG-2, PDGFRa and PDGFRb). Images were acquired as
above for each ROI, and only immunopositive cells (not
processes or fibers) were systematically counted through
manual tagging. The total number of immunopositive cells
for each ROI was expressed in relation to the total area of
ROI.
Statistical analysis
Statistical analysis was carried out using analysis pro-
gram SPSS version 18 for Windows (IBM, Armonk, NY,
U.S.A.). Mann-Whitney U-test and Wilcoxon signed-rank
test were used to compare data between ROIs and Pearson’s
test for clinical pathologic correlations.
Results
Qualitative findings
LFB andMBP (SMI94) sections
A reduction of WM myelinated fibers in the region of
dysplasia compared to normal WM was observed to vary-
ing degree (Figs. 1A,B and 2A,B). In four cases, this
involved the immediate subcortical zone, in the region of
the “U” fibers, whereas in other cases, myelin loss
extended more deeply (Fig. 1A,B). In the normal cortex,
radial bundles of myelinated fibers were clearly defined
with SMI94 in the deeper cortical layers (Fig. 2D),
whereas in the region of dysplasia, the cortical
myeloarchitecture was disorganized, often with prominent
horizontal fiber networks obscuring this normal radial pat-
tern (Fig. 2C).
Neurofilament stained sections (SMI32 and SMI31)
Reduced labeling of axons and processes in the white
matter in the region of dysplasia was observed (Fig. 2E,I)
compared to adjacent white matter (Fig. 2F,J). In addition,
WM axons in the region of dysplasia often appeared thicker
and more tortuous (Fig. 2E,I). Dysmorphic horizontal neu-
rons in the immediate subcortical WM, exhibited coarse,
bipolar processes often running parallel to the cortex
(Fig. 2E inset). In the dysplastic cortex, axon stains
revealed a disorganized network of processes (Fig. 2G,K)
compared to the radial bundles of axons in the normal cortex
(Fig. 2H,L).
MAP2 sections
Dysmorphic neurons with coarse dendrites or surround-
ing processes were observed in theWM in the region of dys-
plasia compared to scattered small, single neurons with fine
processes in the normal white matter (Fig. 2M,N). In the
A B
Figure 1.
Low power views of myelin stained sections (LFB) form two cases of FCD type IIB illustrating the regions of interest (ROIs) used for
the analysis. (A) The white matter pallor extends from the depth of sulcus deep to the white matter, whereas in (B) only the immedi-
ate subcortical zone, that of the U-fibers shows pallor that forms a band running along the bottom of the cortex (arrowheads) and the
overlying cortex shows excess myelination. The ROI indicated are ROI 1 subcortical white matter (WM) in region of dysplasia, ROI2
dysplastic cortex (full thickness) overlying ROI1, ROI 3 normal WM in adjacent cortex, ROI4 normal cortex (full thickness) overlying
ROI 3. (The ROI shown here provide an approximation of the size of the freehand drawn ROI on the immunostained sections.) The
scale bars inA = 800 andB = 1,500 lm.
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dysplastic cortex, MAP2 highlighted the ill-defined bound-
ary between the gray and white matter with prominent, hori-
zontally orientated neurons in the immediate subcortical
region (Fig. 2O) in contrast to a sharper gray-white bound-
ary in the adjacent normal cortex (Fig. 2P).
NG-2, PDGFRa, and b sections
Positive cytoplasmic labeling of cells with similar mor-
phology were identified in all ROIs (Fig. 3), with small,
round nuclei and fine, short multipolar processes with
branch points, particularly visible with NG2 (Fig. 3H) and
PDGFRb (Fig. 3A,I). Additional labeling of vascular struc-
tures was present on PDGFRb sections. Double labeling
confirmed colocalization between PDGFRa and b (Fig. 3I),
but no colocalization between PDGFRa and GFAP,
HLADR, or CD45. The morphology of these multipolar
cells was therefore considered compatible with oligoden-
droglial precursor or progenitor cell types (OPCs)
(Jakovcevski et al., 2009). There was no distinct labeling of
balloon cells in the white matter with these markers.
Figure 2.
Immunohistochemistry for myelin basic protein (SMI94;A–D), nonphosphorylated neurofilament (NP-NFilament SMI32;E–H), phos-
phorylated neurofilament (P-Nfilament SMI31; I–L) and Map2 (microtubule associated protein) in ROI1 (FCD WM), ROI3 (normal
WM), ROI2 (FCD cortex), and ROI4 (normal cortex). Reduction of number of processes was noted in ROI1 with SMI31,32, & 94 anti-
bodies with thick, tortuous fibres present, particularly in SMI32. Inset in (E) shows a dysmorphic neuron in the immediate subcortical
region with thick bipolar processes running horizontally to the cortex. In ROI3 (B, F, J) normal density and size of axons were seen
with all antibodies. In the dysplastic cortex, prominent horizontal fibers were seen with SMI94 (C), obscuring the normal radial orien-
tation observed in normal cortex (D). Similarly in neurofilament stains, disorganized axonal and dendritic processes were seen in the
dysplasia (G, K) relative to the radial organized patterns of normal cortex (H, L). In Map2 stained sections in theWM of the region of
dysplasia (M), dysmorphic neurons and dendrites were present compared to infrequent, small white matter neurons and fine
dendrites in adjacent normal WM (N). In the region of dysplasia (O) Map2 staining highlights the ill-defined border between the gray
and white matter interface with numerous unstained balloon cells and prominent horizontal neurons in the subcortical zone. In the
adjacent cortex, sharper demarcation of cortex and white matter is observed (P). ROI, Region of interest; FCD, Focal cortical dyspla-
sia; WM, white matter; ADJ, adjacent normal cortex. Bar = 60 microns in A to N and 140 microns in O & P.
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CNPase sections
Small, OL cells showed cytoplasmic labeling in all
regions, in addition to labeling of myelinated fibers in the
normal white matter (Fig. 3C,D) with prominent demon-
stration of the cortical radial fiber bundles and horizontal
myelinated fibers and oligodendroglial in layer I in the nor-
mal cortex. There was a qualitative impression of a reduc-
tion of CNPase labeling in the white matter underlying the
dysplasia and disorganized fiber arrangement in the cortex.
NogoA sections
Similar small round cells, albeit fewer in number than
with CNPase, were visible in all ROIs, with labeling
restricted to a thin rim of cytoplasmic staining around the
nucleus (Fig. 3E,F).
Quantitative analysis
There was a significant reduction in the mean MBP label-
ling with SMI94, CNPase, and neurofilament (SMI31) in
ROI1 compared to ROI3 in FCD cases (p < 0.0001;
p < 0.01 and p < 0.05, respectively) (Table 3). No
significant differences in mean cortical MBP labeling or
neurofilament (between ROIs 2 and 4) were noted (p = 0.41
and p = 0.21) despite the abnormal distribution of fibers
observed in the dysplastic zone. Myelin staining values with
SMI94 were lower in ROI1 than three in 16 of the 19 cases
and for neurofilament (SMI31) in 14 of the 19 cases. In the
19 cases, there was a significant correlation between the
MBP (SMI94) and neurofilament (SMI31) labeling index in
ROI1 (p < 0.01) and SMI94 and CNPase (p < 0.05).
Increased mean dendritic staining with Map2 was observed
Figure 3.
Immunohistochemistry for oligodendroglial (OL) and precursor cell types (OPC). Comparison of ROI1 (white matter in the region of
dysplasia [A, C, E]) with ROI3 (adjacent white matter [B, D, F]) positive labeling of cells with PDGFRb (A, B) CNPase (C, D) and
NogoA (E, F) are seen in both ROI. With PDGFRb, small round cells were labeled with fine branching processes, compatible with the
described morphology of OPC, and were visible in both ROI; with CNPase, labeling of small OL in addition to fibers was noted with a
marked reduction in the labeling of fibers in ROI1 (C) compared to ROI3 (D). NogoA labeled infrequent small OL cells in all ROI with
a small, peripheral rim of cytoplasmic labeling. (G) PDGFRa also showed positive round cells in ROI1 and (inset) ROI3. (H) NG2
labeled cells with similar morphology, with fine branching process in ROI3 and in (inset) ROI1 near to an unlabeled balloon cell. (I)
Confocal microscopy confirmed overlap of labeling of PDGFRa and b in cells with multipolar morphology. Bar = 15 microns (A, B,
E, F,G,H, I [including insets]) and 35 microns (C,D).
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in ROI1 compared to ROI3 (Table 3), but the differences
were not significant.
Analysis of OL cell numbers with mature (CNPase,
NogoA) and immature cell markers (PDGFRa, PDGFRb,
and NG2) revealed lower mean cell densities in ROI1 than
ROI3 for all markers apart from PDGFRb, which was
increased in ROI1 (Table 3), although the differences were
not statistically significant. There was a correlation between
the myelin staining in ROI1 with SMI94 and the number of
mature oligodendroglia with NogoA (p < 0.05).
The findings above remained significant for the 18 FCD
type IIB cases alone, excluding the single FCD type IIA
case.
Clinical correlations
There was a significant negative correlation between
duration of seizures (age of onset of epilepsy to age at sur-
gery) and neurofilament (SMI31) (p < 0.001) and MPB
(p < 0.05) labeling index in the white matter in the region
of dysplasia (ROI1). There were also significant positive
correlations between the relative changes in the white
matter labeling [(RO3-RO1)/ROI3] for SMI31 with dura-
tion of epilepsy (p < 0.05) and for CNPase with age of onset
of epilepsy (p < 0.05) (Fig. 4A).
Outcome data available in the 17 operated cases, taken at
the time of last clinical follow-up, showed that six patients
remained seizure-free and nine patients continued to have
seizures, with no data for two patients (Table 1). Correla-
tion with the pathology measures showed significantly
lower mean myelin labeling index with SMI94
(p < 0.0001) and CNPase (p < 0.005) in ROI1 in patients
who remained seizure-free compared to the non–seizure-
free group (Fig. 4B). Mean SMI31 labelling was lower in
the seizure-free group in ROI1 but not significantly so,
whereas OL cell density (with PDGFRb and NOGOA) were
marginally increased.
Discussion
We have confirmed, through quantitative analysis, a sig-
nificant reduction in myelin in the WM in FCD II. This was
accompanied by a parallel reduction in neurofilament stain-
Table 3. Results of quantitative evaluation of FCD cases withmean values shown for each region of interest (ROI) in
the FCD cases
Target structure/
immunomarker
FCD region Adjacent cortex
Significance
(between ROI
and ROI 3)
ROIWM
Mean [SD]
ROI 2
Cortex
Mean [SD]
ROI 3
WM
Mean [SD]
ROI 4
Cortex
Mean [SD]
Myelin labeling (myelin
basic protein)
SMI94
% labeling
33.4 [17.5]
N = 19
20.4 [16.6]
N = 19
55.5 [15.0]
N = 19
22.6 [13.7]
N = 19
p < 0.0001
Axonal labeling
(neurofilament)
SMI31
% labeling
19.7 [10.3]
N = 19
27.4 [15.4]
N = 19
32.3 [13.1]
N = 19
29.6 [18.4]
N = 19
p < 0.01
Dendritic labeling
(microtubule-associated
protein)
MAP2
% labeling
12.2 [9.4]
N = 15
– 10.6 [8.8]
N = 15
–
Mature oligodendroglia
CNPase
% labeling
24.9 [15.9]
N = 12
– 42.5 [16.9]
N = 12
– p < 0.05
CNPase
Cell density 9 105/lm2
22.30 [25.5]
N = 9
10.03 [8.47]
N = 9
26.97 [28.8]
N = 10
8.96 [7.9]
N = 10
NOGOA
Cell density 9 105/lm
0.85 [1.6]
N = 13
0.17 [0.3]
N = 13
5.2 [12.4]
N = 12
0.08 [0.15]
N = 12
Immature oligodendroglia
PDGFR-a
Cell density 9 105/lm2
8.971 [7.75]
N = 9
6.31 [5.38]
N = 9
12.751 [9.69]
N = 10
8.305 [5.67]
N = 10
PDGFR-b
Cell density 9 105/lm2
3.05 [4.5]
N = 14
4.4 [5.8]
N = 10
2.7 [0.46]
N = 13
3.2 [5.3]
N = 9
NG-2
Cell density 9 105/lm2
0.058 [0.076]
N = 6
0.062 [0.088]
N = 2a
0.5662 [0.67]
N = 7
0.097 [0.16]
N = 3
The two main measurements were the overall percentage of ROI labeling (i.e., the “field fraction” or “labeling index”) or the number of positive labeled cells per
ROI (cell density expressed per square micron [lm]).WM = white matter, N = number of cases evaluated for each test. In a proportion of cases, particularly with
aNG2 labeling in cortical region, enumeration of positive cells with image analysis was not possible due to differentiation of background labeling from positive cell
labeling. Statistical analysis between ROI 1 and 3 is shown using nonparametric tests and only p-values of <0.05 are shown
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ing that correlated with the myelin reduction in individual
cases. The less marked reduction in neurofilament than
myelin observed, could be an effect of increased neurofila-
ment-positive dystrophic dendrites in the WM in FCD, as
noted in previous studies (Cepeda et al., 2003).We demon-
strated this in the present study with increased MAP2 label-
ing in the region of dysplasia, which specifically label
dendrites, but not axons, and this could explain the less
significant reduction in neurofilament compared to myelin.
Taking this into consideration, we interpret these findings
that a reduction of myelinated axons (compared to normal
white matter) rather than reduced myelination of axons
likely represents the predominant pathologic cause of the
“hypomyelinated”white matter associated with FCD.
One explanation for this observation is that axon projec-
tions from the overlying dysplastic cortex take abnormal
routes. We noted abnormal organization of myelinated cor-
tical axons and dendrites in FCD, often with an excess of
horizontal or transverse processes. This may be secondary
to the abnormal orientation of neurons in FCD, as previ-
ously shown with intracellular biocytin tracing methods
(Cepeda et al., 2003). The normal polarized state of a
neuron is actively maintained by transcription factors and
closely linked to the mechanisms regulating axonal
pathways as well as the distribution of its dendrites (de la
Torre-Ubieta & Bonni, 2011), and respecification of a den-
drite as an axon may also occur in pathologic conditions
(Gomis-Ruth et al., 2008). One possibility, therefore, is that
dysregulation of these processes occurs in cortical dyspla-
sia, either as a primary or secondary mechanism, with the
formation of the observed abnormal intracortical axoden-
dritic networks and consequent reduction in WM axons.
A more likely hypotheses, however, is that the reduction
in WM axons reflects a reduction in neuronal number in the
overlying dysplastic cortex. We have previously demon-
strated lower mean cortical neuronal densities in FCD II
compared to adjacent normal cortex (Thom et al., 2005),
more recently confirmed by another study (Muhlebner
et al., 2012). Our previous study also showed a trend for a
decline in cortical neuronal density in FCD II, with age
of patient and duration of seizures (Thom et al., 2005).
In addition, in this current study we have observed a decline
of white matter axons in relation to seizure duration in sup-
port of this hypothesis, which suggests that there is progres-
sive degeneration in FCD II with ongoing neuronal and
axonal (and myelin) loss.
We also examined OPC and OL populations in FCD.
Loss of OL function has been implicated in animal models
of tuberous sclerosis with hypomyelination (Ess, 2010).
There is a body of evidence that the neuronal and glial cyto-
pathology in FCD may reflect abnormal cellular maturation
and differentiation, with persisting expression of stem cell
markers demonstrated on balloon cells (Ying et al., 2005;
Najm et al., 2007). Balloon cells have properties of patho-
logic progenitor cells (Yasin et al., 2010), and studies
applying developmental lineage markers suggest that
balloon cells and dysmorphic neurons likely derive from
radial glia or radial migrating ventricular zone progenitors
(Lamparello et al., 2007; Hadjivassiliou et al., 2010).
Related theories propose FCD is a result of events in the late
stages of corticogenesis with localized failure of elimination
of immature subplate and radial glial elements (Cepeda
A
B
Figure 4.
(A) The relative reduction of labeling fraction between region
of interest (ROI) 1 and 3 [(ROI3-1)/ROI3] is plotted for myelin
(SMI94 & CNPase), axons (SMI31) and axons with labeling of
dendrites subtracted in each ROI (SMI31-MAP2) against dura-
tion of epilepsy (time between onset of seizures and surgery)
for the 17 surgical cases in the study. The relative reduction in
values provides more comparable data between cases, taking
into account any variations of staining due to tissue processing
and fixation. There was a significant positive correlation noted
for SMI31 and CNPase. (B) A graph of the mean values for the
field fraction of labeling with myelin basic protein (SMI94),
neurofilament (SMI31), CNPase myelin, and cell density of oli-
godendroglial precursors (PDGF) and mature oligodendroglia
(NogoA) in the white matter associated with FCD II in patients
who were seizure-free at last follow-up compared to patients
who continue to have seizures. Significantly lower myelin stain-
ing (with SMI94 and CNPase) was observed in the seizure-free
patients in this small study group.
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et al., 2006). OL and their progenitor cells have, however,
been little investigated, although a recent study of FCD IIB
demonstrated a reduction in Olig2-positive cells in the white
matter in two-thirds of cases and a correlation between mye-
lin reduction and oligodendroglial numbers (Muhlebner
et al., 2012).
OPC migration and maturation into OL occurs in three
waves and from different origins including the ganglionic
eminence as well as the radial glial cells of the sub-ventricu-
lar zone (Jakovcevski et al., 2009). Their differentiation
and maturation is shown by sequential expression of lineage
markers from PDGFa/NG2 in early OPC to NogoA and
MBP in mature OL (Jakovcevski et al., 2009; Bradl &
Lassmann, 2010; Muhlebner et al., 2012). Of possible rele-
vance to the hypomyelination in FCD, during mid-gestation,
OPCs locate to the transient subplate zone beneath the cortex,
an interlude considered to be relevant to their maturation
and myelination of local axonal projections (Jakovcevski
et al., 2009). Unlike other precursor cell types, all stages of
OPC persist in the cortex and WM through adult life to
replenish OL numbers (Jakovcevski et al., 2009). Previous
studies confirm that NG2-positive cells represent the largest
proliferating cell pool in epilepsy surgical tissues (Geha
et al., 2010). In the current study we were able to identify
the range of OPC and OL cell types in FCD II with our
immunohistochemistry panel. Although for most markers
there were reduced numbers in the region of dysplasia, with
a greater reduction in the WM than dysplastic cortex, the
differences were not numerically significant to control
regions. In our study, PDGFRb immunohistochemistry
revealed cells with similar cyto-morphology to NG2 and
PDGFRa labelling, the latter being more recognized OPC
lineage markers. PDGFRb has previously been identified as
a marker of pericytes in human brain angiogenesis (Virgin-
tino et al., 2007). We also noted vascular staining with
PDGFRb, but this marker has not previously been reported
to label OPC-like cells. Of note, the morphology of the OL
cell types with all markers, in contrast to a previous study
(Muhlebner et al., 2012) appeared normal and we did not
identify any significant labelling of balloon cells with any
OPC markers. Therefore, although we identified some
reduction in OL/OPC number in addition to the myelin in
FCD II white matter, the OL numbers were present in an
appropriate ratio to the level of myelination, in keeping with
findings in the previous study of FCD II by Muhlebner et al.
(2012). There is also limited evidence from our data to sup-
port a significant failure of OLmaturation or cytomorphology
to implicate this cell lineage as the primary or developmen-
tal cause of the local myelin and axon deficiency.
Human myelination of the WM proceeds from the
region of the central sulcus by 15 months towards the
fontal and temporal poles by the 23rd postnatal month
(Kinney et al., 1988). Completion of myelination continues
over decades, projection pathways typically myelinating
before association pathways (Ullen, 2009). We noted the
reduction of myelinated axons was limited to the immedi-
ate subcortical territory of the U-fibres of Meynert in
some FCD cases. The U-fibres, travel in a tangential
rather than radial orientation, forming local cortical-corti-
cal connections as recently mapped by DTI tractography
(Oishi et al., 2008). In other FCD cases, pallor of deep
WM likely represents reduction of longer range afferent
and efferent cortical projections. In Taylor’s original
paper on FCD they also describe cases where the myelin
pathology extended deeply from the cortex and other
cases, where only the immediate or subjacent WM, was
affected (Taylor et al., 1971). In subsequent FCD series
there has been little descriptive neuropathological infor-
mation regarding the topography of myelin depletion,
although is presence frequently recorded (Urbach et al.,
2002; Mackay et al., 2003; Blumcke et al., 2011). We
noted a relationship between age of onset of epilepsy and
severity of reduction of myelin with CNPase in FCD. It is
possible that early seizures interfere with these stages of
myelin maturation which requires investigation in a larger
series, ideally incorporating neuroimaging. DTI studies in
cortical malformations have approached the extent and
nature of WM tract changes (Eriksson et al., 2001; Diehl
et al., 2010) with alterations in diffusivity suggested to
correlated with loss of myelin integrity, axonal density or
directional order of WM (Widjaja et al., 2007). However,
there is a lack of detailed pathological-imaging correla-
tion. In the current study, MRI abnormalities, as blurring
of the grey-white matter junction and abnormal WM
signal intensity on T2-weighted or FLAIR images was
noted. It was not possible to carry out a quantitative neu-
roimaging correlation in the current series as the patients
had been operated and imaged over a 13 year period
using different MR modalities and retrospective coregis-
tration of tissue sample with MRI was not feasible. Fur-
thermore, myelin abnormalities are also present histologically
in other FCD subtypes (Blumcke et al., 2011), with
abnormal superficial cortical myelination noted in FCD
IIIa (Thom et al., 2009) and WM hypomyelination in
FCD IIIb (Thom et al., 2011), the later which may be
misinterpreted as FCD II in conventional MRI (Campos
et al., 2009), including cases in the present study. Further
investigation of differences (or similarities) in myelin
abnormalities between FCD subtypes, with pathology-
imaging coregistration, are warranted to improve pre-
operative recognition and discrimination of these lesions.
In regard to patient outcome in this small series, we
showed significantly lower measures of white matter myeli-
nation in the patients with seizure-free outcome at last
follow-up. It has been reported that completeness of resec-
tion of the dysplastic cortex but not the underlying WM is
necessary for seizure freedom (Wagner et al., 2011) imply-
ing that the extent of WM pathology is not relevant to out-
come. It is possible, in the present series, that the presence
of white matter pathology allowed better discrimination of
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the extent of the lesion onMRI and a more complete cortical
resection, compared to cases without this feature. However,
this is a study of a small number of cases and the prognostic
value of white matter pathology would require verification
in a larger series.
In conclusion, in this study quantifying the pathological
basis of dysmyelination abnormalities in FCD we confirm
primarily a loss of myelinated WM axons but with disorga-
nized patterns of cortical myelination and overall preserva-
tion and representation of OL cells and their precursors. Our
study has highlighted several future lines of investigation to
pursue as to the cause and effects of these integral and
diagnostic pathological changes in the context of FCD.
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